ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
128.197,25
0,00%
S&P 500
5.917,11
0,00%
US Dollar vs BRL
5,77553
0,06%
Bitcoin
97.962,01
3,83%
Brent Oil
73,905
1,46%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Notícias

GSK

Gsk (GSK)

Gsk Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:GSK
DataHoraFonteTítuloCódigoCompanhia
19/11/202412:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
19/11/202406:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
19/11/202404:00RNS Regulatory NewsGSK PLC GLISTEN Trial of Linerixibat Meets EndpointLSE:GSKGsk Plc
14/11/202405:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
14/11/202404:00RNS Regulatory NewsGSK PLC GSK announces overall survival results for BlenrepLSE:GSKGsk Plc
13/11/202412:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
11/11/202412:01RNS Regulatory NewsGSK PLC GSK publishes provisional 2025 dividend datesLSE:GSKGsk Plc
04/11/202413:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
01/11/202412:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
30/10/202406:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
30/10/202404:00RNS Regulatory NewsGSK PLC 3rd Quarter ResultsLSE:GSKGsk Plc
29/10/202409:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
24/10/202405:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
24/10/202403:00RNS Regulatory NewsGSK PLC New positive Arexvy data in younger adults at riskLSE:GSKGsk Plc
16/10/202404:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
16/10/202403:00RNS Regulatory NewsGSK PLC FDA accepts new drug application for gepotidacinLSE:GSKGsk Plc
14/10/202404:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
14/10/202403:00RNS Regulatory NewsGSK PLC Positive results of ANCHOR trials of depemokimabLSE:GSKGsk Plc
10/10/202407:48IH Market NewsU.S. Futures Fall Slightly as Investors Await CPI Data; Oil Prices RiseLSE:GSKGsk Plc
10/10/202405:24Alliance NewsAlliance NewsEXTRA: GSK's Zantac update clears "indigestion" but eyes turn to jabsLSE:GSKGsk Plc
09/10/202415:59Alliance NewsAlliance NewsTOP NEWS: GSK to settle 80,000 Zantac cases for up to USD2.2 billionLSE:GSKGsk Plc
09/10/202413:48RNS Regulatory NewsGSK PLC Zantac (ranitidine) litigation settlementsLSE:GSKGsk Plc
08/10/202409:18Alliance NewsAlliance NewsGSK trial proves RSV vaccine efficacy after three full seasonsLSE:GSKGsk Plc
08/10/202407:45RNS Regulatory NewsGSK PLC Positive efficacy data of Arexvy over 3 seasonsLSE:GSKGsk Plc
24/09/202405:16Alliance NewsAlliance NewsTOP NEWS: GSK celebrates positive EU opinion of liquid Menveo vaccineLSE:GSKGsk Plc
24/09/202403:00RNS Regulatory NewsGSK PLC Positive EU opinion for GSK liquid Menveo vaccineLSE:GSKGsk Plc
18/09/202410:00Alliance NewsAlliance NewsGSK reaches further two settlements regarding ZantacLSE:GSKGsk Plc
18/09/202409:20RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
17/09/202405:18Alliance NewsAlliance NewsGSK says Blenrep combinations accepted for review in JapanLSE:GSKGsk Plc
17/09/202403:00RNS Regulatory NewsGSK PLC Japan Filing Acceptance: Blenrep Multiple MyelomaLSE:GSKGsk Plc
 Apresentando as notícias mais relevantes sobre:LSE:GSK

Seu Histórico Recente

TSX
ACB
Aurora Cannabis
CSE
BEE
Bee Vectoring Technologies
USOTC
AFRAF
Air France KLM (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados